MicroSalt plc (LSE:SALT) has reported record first-half sales of $0.9 million in its B2B bulk segment, reflecting a 72% increase compared with the prior half-year. The company projects further growth, driven by higher volume orders from a major North American client, which could result in total sales surpassing $5 million in 2026. Regulatory delays affecting food colorings have tempered 2025 sales expectations to $2 million, but MicroSalt remains confident in its growth trajectory, supported by a strong sales pipeline and ongoing market expansion.
Financially, MicroSalt faces significant challenges, including negative equity, lack of profitability, and a weak valuation. Technical indicators signal bearish momentum, with the stock currently oversold. While recent corporate developments are positive, they are tempered by these financial and market headwinds.
About MicroSalt plc
MicroSalt plc is an innovative food manufacturing company specializing in a patented, full-flavour, low-sodium salt product. Containing roughly 50% less sodium than conventional salt, it addresses rising demand for healthier alternatives and helps combat cardiovascular health risks. Established in 2018, the company holds a US patent and has 14 additional patent applications globally, positioning itself as a potential disruptor in the reduced-sodium market.
This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.
Leave a Reply